Antimicrobials Labeling Rule Should Allow "Appropriate Use," PhRMA Says

FDA's proposed rule on labeling requirements for systemic antimicrobials should allow for "appropriate treatment" of infections that are suspected to be caused by susceptible microorganisms, the Pharmaceutical Research & Manufacturers of America said in comments to the agency.